This paper compared prostate cancer detection rates and biopsy quality in 16-Gauge (G) and 18G transrectal ultrasound (TRUS)-guided biopsies.
Sixteen gauge needles improve specimen quality but not cancer detection rate in transrectal ultrasound-guided 10-core prostate biopsies.
Inal GH, Oztekin VC, Uğurlu O, Kosan M, Akdemir O, Cetinkaya M
Purpose
Conclusion
Compared to 18G cores, 16G cores were more likely to be >5 mm in length, contain adequate tissue in all cores, have fewer than three fragmented cores, and contain tissue in all cores. However, the cancer detection rates were comparable between the 16G and 18G biopsy groups (24.3% versus 15.8%,) and this held true even when the data was broken down by prostate specific antigen (PSA) level or prostate volume.
Studies (1)
Purpose
This study compared prostate cancer detection rates in 16G and 18G TRUS-guided biopsies. Ten core TRUS-guided biopsies were obtained using either a 16G needle (103 patients) or a 18G needle (101 patients). All patients had elevated prostate specific antigen levels and were undergoing a first biopsy. The patients were randomly assigned to a needle gauge and there were no significant differences in mean PSA, patient age, or prostate volume between groups. Pathology was only performed on seventy-two 16G biopsies and seventy-one 18G biopsies, but histopathology was performed on all biopsies.
Summary of Findings
The 16G cores were significantly more likely to be >5 mm in length than 18G cores (P=0.000). Further, a larger percentage of 16G biopsies than 18G biopsies contained adequate tissue in all cores (75% versus 36.6% ) and had fewer than three fragmented cores (73.7% versus 43.7%, P=0.000). However, the cancer detection rates were comparable between the 16G and 18G biopsy groups (24.3% versus 15.8%, P=0.133) and this held true even when the data was broken down by PSA level or prostate volume.
Biospecimens
TissueProstatePreservation Types
FormalinNone (Fresh)Diagnoses
NeoplasticCarcinomaNeoplasticBenignPlatforms
MorphologyH-and-E microscopyMorphologyLight microscopyPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Biomarker level 10.1-20 ng/ml PSA2.6–4 ng/ml PSA4.1-10 ng/ml PSAPreaquisition Prognostic factor Prostate volume >40 mlProstate volume ≤40 mlBiospecimen Acquisition Needle gauge 16G18G